Nextech Invest Ltd. reported 16 holdings worth US$2.11B as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 14, 2026
Nextech Invest Ltd. reported 16 holdings worth US$2.11B as of Jun 30, 2026. Largest: Revolution Medicines, Inc., Parabilis Medicines, Inc. and Relay Therapeutics, Inc. Filed Aug 14, 2026 (Form 13F).
- Holdings
- 16
- Value as reported
- US$2.11B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Revolution Medicines, Inc. | 7.6M | US$1.42B | 67.6% |
| Parabilis Medicines, Inc. | 4.66M | US$128M | 6.1% |
| Relay Therapeutics, Inc. | 6.78M | US$127M | 6.0% |
| Tyra Biosciences, Inc. | 3.55M | US$114M | 5.4% |
| Alumis Inc. | 3.54M | US$99.6M | 4.7% |
| Oric Pharmaceuticals, Inc. | 7.16M | US$77.6M | 3.7% |
| Kymera Therapeutics, Inc. | 279K | US$32M | 1.5% |
| Zymeworks Inc. | 1.11M | US$29.1M | 1.4% |
| Monte Rosa Therapeutics, Inc. | 761K | US$18.4M | 0.87% |
| Arvinas, Inc. | 1.12M | US$17.1M | 0.81% |
| Cytomx Therapeutics, Inc. | 4.45M | US$16.7M | 0.79% |
| Corvus Pharmaceuticals, Inc. | 450K | US$6.72M | 0.32% |
| Context Therapeutics Inc. | 7.42M | US$4.11M | 0.20% |
| Tango Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Ars Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Cullinan Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Engene Holdings Inc. | 0 | US$0 | 0.00% |